High Medicare spending on prostate cancer screenings, but little benefit for older men
Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings—one-third of which was for men in the ...
Oct 4, 2013
0
0